Insider Transactions in Q2 2024 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,900
-57.5%
|
-
|
|
Jun 12
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
95,862
-2.88%
|
$862,758
$9.15 P/Share
|
|
Jun 12
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
95,862
-2.88%
|
$862,758
$9.15 P/Share
|
|
Jun 11
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
4,138
-0.12%
|
$37,242
$9.0 P/Share
|
|
Jun 11
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
4,138
-0.12%
|
$37,242
$9.0 P/Share
|
|
Jun 07
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,950
-21.65%
|
-
|
|
Jun 04
2024
|
Pratik Shah |
BUY
Bona fide gift
|
Indirect |
1,332,900
+50.0%
|
-
|
|
Jun 04
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,900
-17.79%
|
-
|
|
Jun 04
2024
|
Pratik Shah |
SELL
Other acquisition or disposition
|
Indirect |
2,665,800
-26.25%
|
-
|
|
May 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
89,096
-2.6%
|
$801,864
$9.06 P/Share
|
|
May 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
89,096
-2.6%
|
$801,864
$9.06 P/Share
|
|
May 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
5,147
-0.15%
|
$46,323
$9.05 P/Share
|
|
May 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
5,147
-0.15%
|
$46,323
$9.05 P/Share
|
|
May 14
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
5,757
-0.17%
|
$51,813
$9.01 P/Share
|
|
May 14
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
5,757
-0.17%
|
$51,813
$9.01 P/Share
|
|
May 07
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.87%
|
$900,000
$9.34 P/Share
|
|
May 07
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.87%
|
$900,000
$9.34 P/Share
|
|
Apr 23
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
130,993
+1.9%
|
$130,993
$1.14 P/Share
|
|
Apr 23
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
130,993
+1.9%
|
$130,993
$1.14 P/Share
|
|
Apr 19
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
188,491
+2.16%
|
$188,491
$1.14 P/Share
|
|
Apr 19
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Indirect |
188,491
+2.16%
|
$188,491
$1.14 P/Share
|
|
Apr 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.79%
|
$900,000
$9.28 P/Share
|
|
Apr 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.79%
|
$900,000
$9.28 P/Share
|
|
Apr 09
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.76%
|
$900,000
$9.28 P/Share
|
|
Apr 09
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.76%
|
$900,000
$9.28 P/Share
|